Group One Trading’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Sell
16,100
-94,800
-85% -$6.6M ﹤0.01% 2713
2025
Q4
$7.36M Sell
110,900
-18,900
-15% -$1.22M 0.01% 1173
2025
Q3
$8.73M Buy
129,800
+2,500
+2% +$198K 0.02% 1005
2025
Q2
$11.1M Buy
127,300
+114,900
+927% +$9.01M 0.02% 747
2025
Q1
$847K Sell
12,400
-6,500
-34% -$530K ﹤0.01% 2605
2024
Q4
$1.47M Buy
18,900
+2,200
+13% +$163K ﹤0.01% 2193
2024
Q3
$1.12M Buy
16,700
+14,500
+659% +$1.19M ﹤0.01% 2198
2024
Q2
$249K Sell
2,200
-26,600
-92% -$3.36M ﹤0.01% 3214
2024
Q1
$3.99M Sell
28,800
-35,400
-55% -$4.45M 0.02% 975
2023
Q4
$7.97M Buy
64,200
+27,200
+74% +$2.78M 0.02% 826
2023
Q3
$3.45M Buy
37,000
+5,900
+19% +$665K 0.01% 1192
2023
Q2
$4M Buy
31,100
+3,000
+11% +$363K 0.01% 1143
2023
Q1
$3.26M Sell
28,100
-110,400
-80% -$12.4M 0.01% 1135
2022
Q4
$15.7M Sell
138,500
-12,700
-8% -$1.39M 0.04% 502
2022
Q3
$12.2M Buy
151,200
+12,000
+9% +$1.02M 0.02% 627
2022
Q2
$10.4M Sell
139,200
-43,600
-24% -$3.98M 0.02% 815
2022
Q1
$23.4M Sell
182,800
-79,600
-30% -$8.71M 0.02% 535
2021
Q4
$35.2M Sell
262,400
-208,800
-44% -$30M 0.03% 420
2021
Q3
$64.4M Buy
471,200
+150,800
+47% +$19M 0.07% 211
2021
Q2
$34.2M Sell
320,400
-5,600
-2% -$538K 0.04% 374
2021
Q1
$29.3M Sell
326,000
-96,000
-23% -$9.01M 0.04% 385
2020
Q4
$39M Buy
422,000
+381,200
+934% +$34M 0.07% 247
2020
Q3
$4.21M Buy
40,800
+21,600
+113% +$2.26M 0.01% 1032
2020
Q2
$1.95M Sell
19,200
-34,000
-64% -$3.04M 0.01% 1486
2020
Q1
$3.58M Sell
53,200
-18,400
-26% -$1.14M 0.03% 703
2019
Q4
$3.92M Buy
71,600
+54,000
+307% +$2.56M 0.03% 830
2019
Q3
$657K Buy
17,600
+14,400
+450% +$559K 0.01% 2105
2019
Q2
$120K Buy
+3,200
New +$101K ﹤0.01% 3207
2019
Q1
Sell
-1,600
Closed -$48K 4929
2018
Q4
$48K Sell
1,600
-6,000
-79% -$190K ﹤0.01% 3582
2018
Q3
$272K Sell
7,600
-3,600
-32% -$112K ﹤0.01% 2782
2018
Q2
$266K Sell
11,200
-38,800
-78% -$823K ﹤0.01% 2819
2018
Q1
$927K Buy
50,000
+2,400
+5% +$35.5K 0.01% 1586
2017
Q4
$683K Sell
47,600
-8,000
-14% -$104K ﹤0.01% 2001
2017
Q3
$680K Sell
55,600
-18,800
-25% -$332K 0.01% 1843
2017
Q2
$1.36M Sell
74,400
-88,800
-54% -$1.64M 0.01% 1221
2017
Q1
$3.46M Buy
+163,200
New +$3.19M 0.04% 563
2016
Q4
Sell
-11,200
Closed -$245K 4498
2016
Q3
$245K Buy
+11,200
New +$249K ﹤0.01% 2320
2016
Q2
Sell
-8,000
Closed -$136K 4678
2016
Q1
$136K Buy
+8,000
New +$134K ﹤0.01% 2605
2015
Q4
Sell
-126,000
Closed -$2.71M 4811
2015
Q3
$2.71M Buy
126,000
+56,400
+81% +$1.26M 0.04% 617
2015
Q2
$1.39M Buy
69,600
+2,000
+3% +$35.1K 0.02% 970
2015
Q1
$1.05M Buy
67,600
+37,600
+125% +$568K 0.02% 1037
2014
Q4
$413K Sell
30,000
-56,800
-65% -$695K 0.01% 1697
2014
Q3
$868K Buy
86,800
+61,200
+239% +$626K 0.01% 1205
2014
Q2
$254K Buy
25,600
+1,600
+7% +$14.2K ﹤0.01% 2185
2014
Q1
$248K Buy
+24,000
New +$248K ﹤0.01% 2260

Other funds holding DXCM

Group One Trading's DXCM Position: Q1 2026 in Review

Group One Trading reduced its DexCom (DXCM) stake by 94% in Q1 2026, selling an estimated $1.92M and leaving 1,706 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #4659.

Group One Trading first reported a position in DXCM in Q4 2013 and has held it in 34 quarters since. The position peaked at $17.3M in Q4 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Group One Trading held 1,706 shares of DexCom worth $107K as of Q1 2026.
  • Group One Trading sold 27,571 DexCom shares in Q1 2026, an estimated $1.92M.
  • DexCom made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4659 holding.
  • Group One Trading first reported a position in DexCom in Q4 2013 and has held it in 34 quarters since.
  • Group One Trading's DexCom position peaked at $17.3M in Q4 2020.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.